癌症免疫疗法
TLR7型
癌症研究
免疫疗法
肿瘤微环境
细胞毒性T细胞
化学
树枝状大分子
癌症
癌细胞
免疫系统
受体
免疫学
医学
Toll样受体
体外
生物化学
内科学
先天免疫系统
肿瘤细胞
作者
Jiasi Wu,Jiaxian Li,Na Shu,Qi-Jia Duan,Qi‐Song Tong,Jingyang Zhang,Yong‐Cong Huang,Siyu Yang,Zhibin Zhao,Jin‐Zhi Du
出处
期刊:Nano Research
[Springer Science+Business Media]
日期:2021-05-04
卷期号:15 (1): 510-518
被引量:19
标识
DOI:10.1007/s12274-021-3510-0
摘要
Tumor associated macrophages (TAMs) tend to exhibit tumor-promoting M2 phenotype and contribute to the development of immunosuppressive microenvironment of solid tumors. Reprograming TAMs from M2 into tumoricidal M1 phenotype is robust for stimulating tumor immunosuppressive microenvironment (TIME). In this study, we developed a poly(amidoamine) (PAMAM) derivative dendrimer (denoted as fourth generation-N,N-diethylaminoethyl (G4-DEEA)) for efficient loading of Toll-like receptor 7 and 8 (TLR7/8) agonist (R848) to remodel the TIME for potent cancer immunotherapy. G4-DEEA exhibited a high loading capacity of R848 up to 35.9 wt% by taking advantage of its dendritic structure. The resulting formulation (designated as G4-DEEA@R848) effectively polarized M2 macrophages into M1 phenotype in vitro, and improved the maturation and activation of antigen-presenting cells. In the 4T1 orthotopic breast cancer model, G4-DEEA@R848 showed a stronger tumor inhibitory effect than free drug. The mechanistic studies suggested that G4-DEEA@R848 could significantly stimulate the TIME by repolarizing TAMs into M1 phenotype, reducing the presence of immunosuppressive myeloid cells and increasing the infiltration of tumor cytotoxic T cells. This study provides a simple but effective dendrimer-based strategy to improve the formulation of R848 for improved cancer immunotherapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI